Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WW 3 someday will be quick and very nasty.
.77% to .55% tells the story. They like it, but not enough to jack the %. It used to be ranked 31 on their list, now 38.
ARK is not addicted to PSTI. They used to have a 0.77% weight now at 0.55% +/-. bcs they(ARK NOT PSTI)) are up 30% three yrs in a row, money is flooding into them and they are allocating it to their picks. So the fact they are buying is correct, but they are underbuying PSTI vs their other picks. Its asset allocation pure and simple.
The media will make it go away.
Now 6-8 months in, we will have vaccines soon, the docs know how to Tx it better, and soon, Biden will show death stats are lower under him than Trump. It's all an illusion.
I work in H2 and it is not the answer.
My little town/county (80,000 ppl population) had 100 cases the other day. That's ramps to NY metro size of 25,000 cases/day. When they had 25,000 cases they were screaming for vents and anything, expect stuff from the prez. We have no overwhelmed hospitals, no ppl dead lining the street, no ppl dead for weeks from their apts, etc.
We have ppl wearing masks, going to school, going to the supermarket, etc. Now with Biden, this will all go away in short order.
Start the fear campaign again.
I did waste a couple of minutes;
here is the SEC link to search back 5 years. My search term was 33. Lots of 10-Ks and 10-Qs, couple PRs, couple 8-Ks with bylaw docs, but nothing about 33% get one 2 director seats. Something about 33 1/3% counts as a quorum.
https://www.sec.gov/edgar/search/?r=el#/q=33&dateRange=5y&startdt=2015-09-30&enddt=2020-09-30&category=all&locationType=located&locationCode=all&ciks=0001158780&entityName=PLURISTEM%2520THERAPEUTICS%2520INC%2520(PSTI)%2520(CIK%25200001158780)&page=1
I like the information, I really do. I just would like it with some proof as I have a problem trusting people on MBs.
GL
you have a tendency to say things that are not quite accurate.
I notice you did not reply with proof. I'm certainly glad I did not hurt your feelings.
You see I thought you were talking out your rear end, so I searched the Bylaws and did not see any such provision, which is exactly what I expected.
Please provide a link to Bylaws or a snippet proving this. I don't believe it, sorry to say.
Yes it is a great sign when the big dogs put their coin in, but as the 2 forms show that fdapproved posted, they were given stock, which is not vested yet. It's not the same and they are not 10% holders.
If you are correct, where is the 13F filing for ARKG?? they own > 5% and therefore MUST file a 13F as you insist they own 1.6M shs.
I only see ARK investment (the whole groups) 13F. 1 single 13F which represents ALL ARK funds.
In fact, ARKG funds own about 1.7M which includes ARKG at 1.6M and IRZL at .091M, last I checked.
linked is the LAST 13F filings for Q2.
https://whalewisdom.com/stock/psti
This is incorrect. The investment management account includes what in the ARKG and IRZL.
Can you please tell me how much ARK owns in each fund. IRZL fund dropped some about 2 weeks ago, ARKG buys and sells a bit here and there. None other have any and the 2 I listed only have about 1.6M. Not close to 11%.
And the week after and the week after, etc to infinity.
Which page of the 10-k does it say this? I read it and don't believe it.
I expect you will disagree, but IIRC 150 employees so that's about 32,000 for each one. Seems a bit excessive to me, unless they need to expand and will be offering inducement grants.
Giddy Down!
Dec 1st!. The wait will be wonderful!
I don't think shipping/storing these temps will be an issue. Note CLSD recently bought part of Chart(maker of cryogenic vessels). CLSD is a shipper of vaccines and GT material. So my guess is CLSD sees the vaccine (as well as GT/CT ) business ballooning soon.
I was reading up on the Stempeutics CLI data. I can only find the phase 2 data (not Phase 3). The AFS data was only a short mention, but not impressive. It appears their dose is about 1/2 of PSTIs. This on their COVID thoughts.
Stempeutics Research, a group company of Manipal Education and Medical Group (MEMG), has partnered with Global Consortium of cell therapy companies seeking European Commission Funding to Fight Against Corona (FAC). Under this partnership, Stempeutics will export its stem cell product Stempeucel subject to regulatory approvals to treat critically ill COVID-19 patients with lung disease. First the product will be clinically tested and upon successful outcomes, it intends to export the product on a regular basis. In this connection it is signing up an alliance with Educell Ltd, Slovenia. Currently, no specific drugs or vaccines are available to cure the patients with COVID-19 infection. Mortality in COVID-19 infected patients with the inflammatory lung condition ARDS (acute respiratory distress syndrome) is reported to approach 50%, and is associated with older age, co-morbidities such as diabetes, cardiovascular disease, COPD (chronic obstructive pulmonary disease), higher disease severity, and elevated markers of inflammation. Current therapeutic interventions with the exception of ventilators/respirators which are in very short supply do not appear to be improving in-hospital survival patients, especially in severe cases. A promising new therapy for the ARDS, the terminal stage of COVID-19, using MSCs can quickly (2-4 days) reduce inflammation of the lung tissue, and allow patients to more quickly come off of the ventilatory support and hopefully fully recover with less significant lung damage. Stempeucel is an allogeneic, off the shelf, pooled mesenchymal stromal cells having anti- inflammatory and immune-modulatory properties which prevents the over activation of the immune system. The product exhibits a wide range of potent therapeutic properties. The product exhibits potent immunomodulatory and anti-inflammatory properties which could help in reducing the inflammation caused due to the cytokine storm elicited by the body’s immune cells in response to SARS-CoV-2 (COVID-19) related infection in the lungs. Also, the growth factor, Angiopoietin-1 (Ang-1) is effective in reducing alveolar epithelium permeability in the lung. Hence it is envisaged, Stempeucel will reduce the fatal symptoms of COVID -19 induced pneumonia and its progression to ARDS. Dr. Miomir Knezevic, Leader, Global Consortium and Founder, Educell said that Stempeucel is already designated as an ATMP1 in Europe and also Stempeucel technology has been patented in many countries in Europe. Stempeutics manufacturing process is scalable and the product is affordable – which are key to meet the demands of COVID-19 patients. According to BN Manohar, CEO, Stempeutics, from the clinical data using Stempeucel in different clinical trials in other indications it may be postulated that Stempeucel has the potential capability for treating COVID-19 infection. Together with the safety profile observed from DCGI approved clinical trials involving more than 350 patients injected with Stempeucel by different routes of injection, this therapy may help in mitigating the lung tissue damaging effects of COVID-19 infection”. Dr. Stephen Minger, scientific advisor for the global consortium and ex global director of R&D, cell technologies GE Healthcare said that treating ARDS patients with allogeneic expanded bone marrow derived MSCs could alleviate and ameliorate lung inflammation and compromised lung function and significantly reduce the time required for patients to be ventilated. Dr. Raviraja N S, sr. director business development and innovation, Stempeutics, said, “Given the severe shortage of ventilators in the world, and the high mortality rate of patients who develop ARDS could drastically impact on the healthcare burden.
I changed the image to reflect the WHOLE "Locations" info. Still recruiting on my computer.
I'm not even sure it matters. 3 sites recruiting for 140 pts, will still take a while.
I clicked your link, IT SAYS RECRUITING!
NO ERROR!
You must work there and your mad bcs you did not get the memo.
uploaded image showing Mercy recruiting
upload to onedrive, then share, then copy the link here.
If I could post a pic on this platform I would. This link has it and updated today (8/25/20). Your initial link had it as well.
https://clinicaltrials.gov/ct2/show/NCT04389450?term=pluristem&draw=2&rank=1
it says right on your link, as I said.
Mercy Medical Center Recruiting
Looks like the last update was to start recruiting at Mercy.
Reeks of pressure on the FDA to get off their duffs to do something. Kind of like when a boss tells an employee to get busy.
We are burning a $1T/Q +/-, something is better than nothing right now.
EUA today right? or was it yesterday, or tomorrow?
Too many rumors and predictions to keep straight.
Not pushing these guys but the innovation is whats important. I mentioned earlier 100k/day, but is 100M/week they can make. Now they are not FDA proven, and I'm not sure how well they work, but likely better than the tissue DIY projects floating around.
We've been hard at work, figuring out how we can help through COVID-19. Masks are extremely short in supply and we've designed a mask that can solve the shortage. We can make 100 million masks a week on our Los Angeles cutting floor. We are joining forces with the people on the front lines to get masks into the hands of those who need them most. More to come!
https://www.facebook.com/bellaclothing/videos/1088071108234854/?t=22
Just found Lombardy region numbers:
pop=10M / 40k cases for 253 ppl per case. So NY is worse than Lombardy ATM, for cases, not deaths.
Exactly, do the per capita on FL vs NY. Here is a sample, population/cases. NY may be in trouble, but many so-called hot spots are much less...hot. It would be interesting to compare it to Italy, Germany, etc.
NYC 337
Nassau Co 294
Suffolk Co 441
Westchester Co 163
King Co 1,395
Snohomish Co 878
LA Co 6,825
Santa Clara Co 3,362
my wife had a video of an innovative textile co. they had a laser cutter and some kind of fabric, made with no loops, cut slits at 3 places on each side. So no labor, cut, box and ship. They can make 100k per day (but I can't find the video they had).
https://www.bellacanvas.com/product/ST323/Guard-Facemask.html
8% of 6161 is 492 and 80 of that is 16%, not sure that's great or horrible, sounds in line. It's not the 35% of cases on vents supposedly like NOLA. Can you comment even if roughly how many of those are ICU and vents?
But while no walk in the park I expect, encouraging!
1 month ago, we needed (conventional wisdom) N95 masks to protect us(few were available, fewer if any now). Now there are tons of videos of ppl making them out of all sorts of things; denim for god's sake.
We bought a couple of boxes of simple ones 6-8 weeks ago when the noise started in the US. These simple ones are not 'taking' from the hospitals, bcs they would not want these cheap things.
We're a country of 330M(+/-) ppl. 3M PRd ramping production to 1B / yr or 3 masks per person per yr, from 3M. It's ludicrous to think every person in the US and have masks available anytime soon, distributed properly, affordable, etc. IMO hopefully the good ones are focused on the HCWs and someone can run a test to see if denim actually does 1 bit of good.
Perhaps you should add a liquor store to your list.
Testing is ongoing and some signs (although still small and early) that there is some immunity.
Heres 1 snippet and there are others:
“You probably would make a good immune response before you even become symptomatic again and might really blunt the course of the disease,” Dr. Krammer said.
https://www.nytimes.com/2020/03/25/health/coronavirus-immunity-antibodies.html
It stands to reason there's some immunity for some time after exposure. Also RWE from say Wuhan would indicate after exposure its more difficult to spread like wildfire thru a population.
all exposed (even those that did not know it) will be immune or a high % will be.
He only days ago turned his code over to google or someone like that to fix it up and distribute it. They probably found some error in there. OOPS.
It all depends on where you draw the country lines. News harped on the US soon becoming the #1 hot spot, terrible here, pain coming, worse than China. The EU; 28 give or take countries combined are 3x or 4x cases than the US and in about 1/3 the landmass. Pain may very well be coming, IDK. One of the casualties here IMO, is truth in journalism.